Report Detail
Global (United States, European Union and China) Human Rotavirus Vaccine Market Research Report 2019-2025
- RnM3579835 |
- 08 July, 2019 |
- Global |
- 111 Pages |
- QYResearch |
- Pharma & Healthcare
Rotavirus vaccine is used to protect against rotavirus infections which cause severe diarrhoea among young children. Symptoms of rotavirus infection include severe diarrhoea, vomiting, fever, and abdominal pain which can result in disease.
Rotavirus vaccine is administered by mouth and requires two or three doses starting around six weeks of age. The vaccine first became available in the United States in 2006.
In 2019, the market size of Human Rotavirus Vaccine is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Human Rotavirus Vaccine.
This report studies the global market size of Human Rotavirus Vaccine, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Human Rotavirus Vaccine sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Bharat Biotech
Merck
GlaxoSmithKline
...
Market Segment by Product Type
Rotarix
RotaTeq
Rotavac
Rotavin-M1
Lanzhou lamb
Others
Market Segment by Application
Hospitals & Clinics
Academic And Research
Others
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Human Rotavirus Vaccine status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Human Rotavirus Vaccine manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Human Rotavirus Vaccine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Human Rotavirus Vaccine Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Rotarix
- 1.3.3 RotaTeq
- 1.3.4 Rotavac
- 1.3.5 Rotavin-M1
- 1.3.6 Lanzhou lamb
- 1.3.7 Others
- 1.4 Market Segment by Application
- 1.4.1 Global Human Rotavirus Vaccine Market Share by Application (2019-2025)
- 1.4.2 Hospitals & Clinics
- 1.4.3 Academic And Research
- 1.4.4 Others
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Human Rotavirus Vaccine Market Size
- 2.1.1 Global Human Rotavirus Vaccine Revenue 2014-2025
- 2.1.2 Global Human Rotavirus Vaccine Sales 2014-2025
- 2.2 Human Rotavirus Vaccine Growth Rate by Regions
- 2.2.1 Global Human Rotavirus Vaccine Sales by Regions 2014-2019
- 2.2.2 Global Human Rotavirus Vaccine Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Human Rotavirus Vaccine Sales by Manufacturers
- 3.1.1 Human Rotavirus Vaccine Sales by Manufacturers 2014-2019
- 3.1.2 Human Rotavirus Vaccine Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Human Rotavirus Vaccine Revenue by Manufacturers (2014-2019)
- 3.2.2 Human Rotavirus Vaccine Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Human Rotavirus Vaccine Market Concentration Ratio (CR5 and HHI)
- 3.3 Human Rotavirus Vaccine Price by Manufacturers
- 3.4 Key Manufacturers Human Rotavirus Vaccine Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Human Rotavirus Vaccine Market
- 3.6 Key Manufacturers Human Rotavirus Vaccine Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Rotarix Sales and Revenue (2014-2019)
- 4.1.2 RotaTeq Sales and Revenue (2014-2019)
- 4.1.3 Rotavac Sales and Revenue (2014-2019)
- 4.1.4 Rotavin-M1 Sales and Revenue (2014-2019)
- 4.1.5 Lanzhou lamb Sales and Revenue (2014-2019)
- 4.1.6 Others Sales and Revenue (2014-2019)
- 4.2 Global Human Rotavirus Vaccine Sales Market Share by Type
- 4.3 Global Human Rotavirus Vaccine Revenue Market Share by Type
- 4.4 Human Rotavirus Vaccine Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Human Rotavirus Vaccine Sales by Application
6 United States
- 6.1 United States Human Rotavirus Vaccine Breakdown Data by Company
- 6.2 United States Human Rotavirus Vaccine Breakdown Data by Type
- 6.3 United States Human Rotavirus Vaccine Breakdown Data by Application
7 European Union
- 7.1 European Union Human Rotavirus Vaccine Breakdown Data by Company
- 7.2 European Union Human Rotavirus Vaccine Breakdown Data by Type
- 7.3 European Union Human Rotavirus Vaccine Breakdown Data by Application
8 China
- 8.1 China Human Rotavirus Vaccine Breakdown Data by Company
- 8.2 China Human Rotavirus Vaccine Breakdown Data by Type
- 8.3 China Human Rotavirus Vaccine Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Human Rotavirus Vaccine Breakdown Data by Company
- 9.2 Rest of World Human Rotavirus Vaccine Breakdown Data by Type
- 9.3 Rest of World Human Rotavirus Vaccine Breakdown Data by Application
- 9.4 Rest of World Human Rotavirus Vaccine Breakdown Data by Countries
- 9.4.1 Rest of World Human Rotavirus Vaccine Sales by Countries
- 9.4.2 Rest of World Human Rotavirus Vaccine Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Bharat Biotech
- 10.1.1 Bharat Biotech Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Human Rotavirus Vaccine
- 10.1.4 Human Rotavirus Vaccine Product Introduction
- 10.1.5 Bharat Biotech Recent Development
- 10.2 Merck
- 10.2.1 Merck Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Human Rotavirus Vaccine
- 10.2.4 Human Rotavirus Vaccine Product Introduction
- 10.2.5 Merck Recent Development
- 10.3 GlaxoSmithKline
- 10.3.1 GlaxoSmithKline Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Human Rotavirus Vaccine
- 10.3.4 Human Rotavirus Vaccine Product Introduction
- 10.3.5 GlaxoSmithKline Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Human Rotavirus Vaccine Sales Channels
- 11.2.2 Human Rotavirus Vaccine Distributors
- 11.3 Human Rotavirus Vaccine Customers
12 Market Forecast
- 12.1 Global Human Rotavirus Vaccine Sales and Revenue Forecast 2019-2025
- 12.2 Global Human Rotavirus Vaccine Sales Forecast by Type
- 12.3 Global Human Rotavirus Vaccine Sales Forecast by Application
- 12.4 Human Rotavirus Vaccine Forecast by Regions
- 12.4.1 Global Human Rotavirus Vaccine Sales Forecast by Regions 2019-2025
- 12.4.2 Global Human Rotavirus Vaccine Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Human Rotavirus Vaccine. Industry analysis & Market Report on Human Rotavirus Vaccine is a syndicated market report, published as Global (United States, European Union and China) Human Rotavirus Vaccine Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Human Rotavirus Vaccine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
